|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 26.25 CNY | +1.47% |
|
+10.34% | -0.19% |
| 10/07 | China Includes Hubei Jumpcan Pharmaceutical's Granules for Colds in Children in Essential Drug List | MT |
| 09/06 | Jumpcan Pharma Gets Registration Certificate for Marboxil Tablets | MT |
| Market Cap | 24.19B 3.57B 3.12B 2.89B 2.65B 5.01B 344B 5.1B 34.43B 13.53B 168B 13.41B 13.12B 580B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 13.21B 1.95B 1.7B 1.58B 1.45B 2.74B 188B 2.78B 18.8B 7.38B 91.75B 7.32B 7.16B 317B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
37.54% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | +1.47% | ||
| 1 week | +10.34% | ||
| Current month | +18.30% | ||
| 1 month | -2.63% | ||
| 3 months | +3.75% | ||
| 6 months | -1.02% | ||
| Current year | -0.19% |
| 1 week | 23.5 |  | 26.4 |
| 1 month | 21.13 | | 27.49 |
| Current year | 21.13 | | 29.6 |
| 1 year | 21.13 | | 29.6 |
| 3 years | 21.13 | | 45.18 |
| 5 years | 14.37 | | 45.18 |
| 10 years | 14.37 | | 54.97 |
| Manager | Title | Age | Since |
|---|---|---|---|
Fei Cao
CEO | Chief Executive Officer | 43 | 20/12/2019 |
Hong Cun Yan
DFI | Director of Finance/CFO | 58 | 26/09/2022 |
Zhigang Chang
IRC | Investor Relations Contact | 29 | 22/07/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Long Xiang Cao
CHM | Chairman | 69 | 10/03/2014 |
Qu Rong Huang
BRD | Director/Board Member | 64 | 10/03/2014 |
Fei Cao
BRD | Director/Board Member | 43 | 10/03/2014 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 1/12/25 | Buy | Director | 30,000 | 0.0033% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.47% | +10.34% | -0.27% | -4.44% | 3.52B | |
| +2.58% | +7.07% | -6.28% | -4.02% | 13.39B | |
| +6.65% | +15.09% | -24.06% | -48.33% | 5.11B | |
| +2.70% | +9.38% | +4.81% | +0.43% | 4.72B | |
| -0.34% | +13.00% | +17.51% | -30.48% | 4.3B | |
| +0.57% | -2.60% | +11.35% | -2.80% | 3.81B | |
| +4.19% | +13.30% | +2.31% | +15.27% | 3.37B | |
| +0.75% | +2.67% | -9.16% | -19.75% | 2.5B | |
| +0.57% | +5.25% | +1.50% | +55.11% | 1.91B | |
| +2.42% | +9.25% | -1.79% | -6.35% | 1.8B | |
| Average | +2.16% | +9.03% | -0.41% | -4.54% | 4.44B | |
| Weighted average by Cap. | +2.44% | +8.92% | -1.85% | -8.12% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | 1.72B 255M 222M 206M 189M 357M 24.52B 364M 2.45B 964M 11.98B 956M 935M 41.35B | - |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/07/26 | CNY 26.25 | +1.47% | 8,729,828 |
| 15/07/26 | CNY 25.87 | +2.46% | 9,691,121 |
| 14/07/26 | CNY 25.25 | +2.60% | 8,440,479 |
| 13/07/26 | CNY 24.61 | +2.71% | 8,313,277 |
| 10/07/26 | CNY 23.96 | -0.58% | 6,180,996 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 600566 Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition